Annual Drug Patent Expirations for KUVAN
Kuvan is a drug marketed by Biomarin Pharm and is included in two NDAs. It is available from two suppliers. There are eleven patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for KUVAN.
This drug has sixteen patent family members in seventeen countries.
The generic ingredient in KUVAN is sapropterin dihydrochloride. Two suppliers are listed for this compound. Additional details are available on the sapropterin dihydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com